OpenVSafe by OpenVAERS
Search V-safe

VEQ-29150-76174

2 vaccinations 2 coded responses 10 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
760 / TX
Registered
2021-04-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-01
    Registered in v-safe
  2. 2021-04-01
    Dose 1 — Moderna
  3. 2021-04-01
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-04-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work
    Adult check-in
  5. 2021-04-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Itching · None
    Adult check-in
  6. 2021-04-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  7. 2021-04-06
    Survey response — days 1–6 daily, dose 1
    MedDRA: Oropharyngeal pain, Sneezing — Feeling: Fair · Fever · Headache, Fatigue or tiredness, Nausea
    Free text: Sore throat, sneezing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-10
    Health check-in — day 7, dose 1
    Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness
    Adult check-in
  9. 2021-04-29
    Dose 2 — Moderna
  10. 2021-04-29
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Headache, Nausea, Abdominal pain · Be unable to work
    Adult check-in
  11. 2021-05-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness, Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain
    Adult check-in
  12. 2021-05-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Itching · Headache, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  13. 2022-04-29
    Survey response — 12 months, dose 2
    MedDRA: Hepatic steatosis — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Fatty Liver Disease
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-04-29
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  15. 2022-05-02

Vaccinations

DoseDateManufacturerCo-administered
12021-04-01Moderna
22021-04-29Moderna

Call center

ReportedOutcomeVAERS-related outcome
2022-04-29 Unsuccessful

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-06

Systemic reaction (other): Sore throat, sneezing

Release 11 — 12 months, dose 2

2022-04-29

Symptoms: Fatty Liver Disease

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHepatic steatosis · · ✓
SROOropharyngeal pain ✓ ✓ ✓
SROSneezing ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release